BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33594909)

  • 1. Adequacy of Unenhanced MRI for Surveillance of Small (Clinical T1a) Solid Renal Masses.
    Mawi H; Narine R; Schieda N
    AJR Am J Roentgenol; 2021 Apr; 216(4):960-966. PubMed ID: 33594909
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Clear Cell Likelihood Score on MRI and Growth Kinetics of Small Solid Renal Masses on Active Surveillance.
    Rasmussen RG; Xi Y; Sibley RC; Lee CJ; Cadeddu JA; Pedrosa I
    AJR Am J Roentgenol; 2022 Jan; 218(1):101-110. PubMed ID: 34286596
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic Performance and Interreader Agreement of the MRI Clear Cell Likelihood Score for Characterization of cT1a and cT1b Solid Renal Masses: An External Validation Study.
    Dunn M; Linehan V; Clarke SE; Keough V; Nelson R; Costa AF
    AJR Am J Roentgenol; 2022 Nov; 219(5):793-803. PubMed ID: 35642765
    [No Abstract]   [Full Text] [Related]  

  • 4. Exophytic renal masses: angular interface with renal parenchyma for distinguishing benign from malignant lesions at MR imaging.
    Verma SK; Mitchell DG; Yang R; Roth CG; O'Kane P; Verma M; Parker L
    Radiology; 2010 May; 255(2):501-7. PubMed ID: 20160001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI evaluation of small (<4cm) solid renal masses: multivariate modeling improves diagnostic accuracy for angiomyolipoma without visible fat compared to univariate analysis.
    Schieda N; Dilauro M; Moosavi B; Hodgdon T; Cron GO; McInnes MD; Flood TA
    Eur Radiol; 2016 Jul; 26(7):2242-51. PubMed ID: 26486936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
    Halefoglu AM; Ozagari AA
    Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Identify Clear Cell Renal Cell Carcinoma in cT1a Renal Masses.
    Canvasser NE; Kay FU; Xi Y; Pinho DF; Costa D; de Leon AD; Khatri G; Leyendecker JR; Yokoo T; Lay A; Kavoussi N; Koseoglu E; Cadeddu JA; Pedrosa I
    J Urol; 2017 Oct; 198(4):780-786. PubMed ID: 28457802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes.
    Serter A; Onur MR; Coban G; Yildiz P; Armagan A; Kocakoc E
    Abdom Radiol (NY); 2021 Mar; 46(3):1041-1052. PubMed ID: 32930832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Contrast-Enhanced Multiphase Renal Protocol CT Versus MRI for Diagnosis of Papillary Renal Cell Carcinoma.
    Dilauro M; Quon M; McInnes MD; Vakili M; Chung A; Flood TA; Schieda N
    AJR Am J Roentgenol; 2016 Feb; 206(2):319-25. PubMed ID: 26797358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a free-breathing respiratory-triggered (Navigator) 3-D T1-weighted (T1W) gradient recalled echo sequence (LAVA) for detection of enhancement in cystic and solid renal masses.
    Tu W; Alzahrani A; Currin S; Walsh C; Narayanasamy S; McInnes MDF; Schieda N
    Eur Radiol; 2019 May; 29(5):2507-2517. PubMed ID: 30506224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Small Renal Tumors With Magnetic Resonance Elastography: A Feasibility Study.
    Prezzi D; Neji R; Kelly-Morland C; Verma H; OʼBrien T; Challacombe B; Fernando A; Chandra A; Sinkus R; Goh V
    Invest Radiol; 2018 Jun; 53(6):344-351. PubMed ID: 29462024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation and Degree of Enhancement With Conventional 120-kVp Polychromatic CT and 70-keV Monochromatic Rapid Kilovoltage-Switching Dual-Energy CT in Cystic and Solid Renal Masses.
    Krishna S; Sadoughi N; McInnes MDF; Chatelain R; MacDonald DB; Schieda N
    AJR Am J Roentgenol; 2018 Oct; 211(4):789-796. PubMed ID: 30106611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonographic Features of Small (< 4 cm) Renal Tumors With Low Signal Intensity on T2-Weighted MR Images: Differentiating Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma.
    Park KJ; Kim MH; Kim JK; Cho KS
    AJR Am J Roentgenol; 2018 Sep; 211(3):605-613. PubMed ID: 30040467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: implications for alternative response criteria.
    Krajewski KM; Nishino M; Franchetti Y; Ramaiya NH; Van den Abbeele AD; Choueiri TK
    Cancer; 2014 Mar; 120(5):711-21. PubMed ID: 24264883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of MRI Sequences for Evaluation of Dural Venous Sinus Thrombosis.
    Sadigh G; Mullins ME; Saindane AM
    AJR Am J Roentgenol; 2016 Jun; 206(6):1298-306. PubMed ID: 27010526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months.
    Merkle EM; Nour SG; Lewin JS
    Radiology; 2005 Jun; 235(3):1065-71. PubMed ID: 15914485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of MRI to Differentiate Clear Cell Renal Cell Carcinoma Adrenal Metastases From Adrenal Adenomas.
    Schieda N; Krishna S; McInnes MDF; Moosavi B; Alrashed A; Moreland R; Siegelman ES
    AJR Am J Roentgenol; 2017 Sep; 209(3):W152-W159. PubMed ID: 28742373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of small (<4cm) solid renal masses by computed tomography and magnetic resonance imaging: Current evidence and further development.
    Schieda N; Lim RS; McInnes MDF; Thomassin I; Renard-Penna R; Tavolaro S; Cornelis FH
    Diagn Interv Imaging; 2018; 99(7-8):443-455. PubMed ID: 29606371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of benign from malignant solid renal lesions with MRI-based radiomics and machine learning.
    Massa'a RN; Stoeckl EM; Lubner MG; Smith D; Mao L; Shapiro DD; Abel EJ; Wentland AL
    Abdom Radiol (NY); 2022 Aug; 47(8):2896-2904. PubMed ID: 35723716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of growth rate of solid renal masses: utility of MR imaging features--preliminary experience.
    Dodelzon K; Mussi TC; Babb JS; Taneja SS; Rosenkrantz AB
    Radiology; 2012 Mar; 262(3):884-93. PubMed ID: 22267588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.